Clinical Nephrology, Volume 75 (2011) - April (374 - 379)

Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy
G. Colucci*, C. Manno*, G. Grandaliano, F.P. Schena
Renal, Dialysis and Transplant Unit, Department of Emergency and Organ Transplant, University of Bari, Bari, Italy

*The Authors contributed equally

Add to Cart  

 

DOI 10.5414/CNP75374

Abstract

Membranoproliferative glomerulonephritis associated with Type II cryoglobulinemia is the predominant type of HCV-related glomerulonephritis. Immunosuppressive and anti-viral therapy is alternately used to treat it, but the results are not always satisfactory or lasting. In this paper we report 3 cases of cryoglobulinemic membranoproliferative glomerulonephritis, treated with different and personalized therapeutic approaches by using conventional therapy and new drugs such as mycophenolate mofetil and rituximab. Our case series report emphasizes the importance of choosing the treatment for each patient, taking into account many factors: age, severity of liver and renal involvement, extra-renal manifestations, any previous treatment, contraindications or adverse events and last but not least the balance between immunosuppression and virus activity.

Author Details

Authors

Departments

  • Renal, Dialysis and Transplant Unit, Department of Emergency and Organ Transplant, University of Bari, Bari, Italy

    *The Authors contributed equally

Address

F.P. Schena, MD, FASN
Professor of Nephrology
Renal, Dialysis and Transplant Unit
Department of Emergency and Organ Transplant
University of Bari, Policlinico
Piazza G. Cesare 11, 70124 Bari, Italy
Email: [email protected]

Log in for Subscribers

Citation

G. Colucci, C. Manno, G. Grandaliano and F.P. Schena. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy. 2011; 75: 374-379. doi: 10.5414/CNP75374.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart